Cargando…

Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System

In current times, DNA vaccines are seen as a promising approach to treat and prevent diseases, such as virus infections and cancer. Aiming at the production of a functional and effective plasmid DNA (pDNA) delivery system, four chitosan polymers, differing in the molecular weight, were studied using...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodolfo, Carlos, Eusébio, Dalinda, Ventura, Cathy, Nunes, Renato, Florindo, Helena F., Costa, Diana, Sousa, Ângela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471690/
https://www.ncbi.nlm.nih.gov/pubmed/34575445
http://dx.doi.org/10.3390/pharmaceutics13091369
_version_ 1784574532819877888
author Rodolfo, Carlos
Eusébio, Dalinda
Ventura, Cathy
Nunes, Renato
Florindo, Helena F.
Costa, Diana
Sousa, Ângela
author_facet Rodolfo, Carlos
Eusébio, Dalinda
Ventura, Cathy
Nunes, Renato
Florindo, Helena F.
Costa, Diana
Sousa, Ângela
author_sort Rodolfo, Carlos
collection PubMed
description In current times, DNA vaccines are seen as a promising approach to treat and prevent diseases, such as virus infections and cancer. Aiming at the production of a functional and effective plasmid DNA (pDNA) delivery system, four chitosan polymers, differing in the molecular weight, were studied using the design of experiments (DoE) tool. These gene delivery systems were formulated by ionotropic gelation and exploring the chitosan and TPP concentrations as DoE inputs to maximize the nanoparticle positive charge and minimize their size and polydispersity index (PDI) as DoE outputs. The obtained linear and quadratic models were statistically significant (p-value < 0.05) and non-significant lack of fit, with suitable coefficient of determination and the respective optimal points successfully validated. Furthermore, morphology, stability and cytotoxicity assays were performed to evaluate the endurance of these systems over time and their further potential for future in vitro studies. The subsequent optimization process was successful achieved for the delivery systems based on the four chitosan polymers, in which the smallest particle size was obtained for the carrier containing the 5 kDa chitosan (~82 nm), while the nanosystem prepared with the high molecular weight (HMW) chitosan displayed the highest zeta potential (~+26.8 mV). Delivery systems were stable in the formulation buffer after a month and did not exhibit toxicity for the cells. In this sense, DoE revealed to be a powerful tool to explore and tailor the characteristics of chitosan/pDNA nanosystems significantly contributing to unraveling an optimum carrier for advancing the DNA vaccines delivery field.
format Online
Article
Text
id pubmed-8471690
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84716902021-09-28 Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System Rodolfo, Carlos Eusébio, Dalinda Ventura, Cathy Nunes, Renato Florindo, Helena F. Costa, Diana Sousa, Ângela Pharmaceutics Article In current times, DNA vaccines are seen as a promising approach to treat and prevent diseases, such as virus infections and cancer. Aiming at the production of a functional and effective plasmid DNA (pDNA) delivery system, four chitosan polymers, differing in the molecular weight, were studied using the design of experiments (DoE) tool. These gene delivery systems were formulated by ionotropic gelation and exploring the chitosan and TPP concentrations as DoE inputs to maximize the nanoparticle positive charge and minimize their size and polydispersity index (PDI) as DoE outputs. The obtained linear and quadratic models were statistically significant (p-value < 0.05) and non-significant lack of fit, with suitable coefficient of determination and the respective optimal points successfully validated. Furthermore, morphology, stability and cytotoxicity assays were performed to evaluate the endurance of these systems over time and their further potential for future in vitro studies. The subsequent optimization process was successful achieved for the delivery systems based on the four chitosan polymers, in which the smallest particle size was obtained for the carrier containing the 5 kDa chitosan (~82 nm), while the nanosystem prepared with the high molecular weight (HMW) chitosan displayed the highest zeta potential (~+26.8 mV). Delivery systems were stable in the formulation buffer after a month and did not exhibit toxicity for the cells. In this sense, DoE revealed to be a powerful tool to explore and tailor the characteristics of chitosan/pDNA nanosystems significantly contributing to unraveling an optimum carrier for advancing the DNA vaccines delivery field. MDPI 2021-08-31 /pmc/articles/PMC8471690/ /pubmed/34575445 http://dx.doi.org/10.3390/pharmaceutics13091369 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rodolfo, Carlos
Eusébio, Dalinda
Ventura, Cathy
Nunes, Renato
Florindo, Helena F.
Costa, Diana
Sousa, Ângela
Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System
title Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System
title_full Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System
title_fullStr Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System
title_full_unstemmed Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System
title_short Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System
title_sort design of experiments to achieve an efficient chitosan-based dna vaccine delivery system
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471690/
https://www.ncbi.nlm.nih.gov/pubmed/34575445
http://dx.doi.org/10.3390/pharmaceutics13091369
work_keys_str_mv AT rodolfocarlos designofexperimentstoachieveanefficientchitosanbaseddnavaccinedeliverysystem
AT eusebiodalinda designofexperimentstoachieveanefficientchitosanbaseddnavaccinedeliverysystem
AT venturacathy designofexperimentstoachieveanefficientchitosanbaseddnavaccinedeliverysystem
AT nunesrenato designofexperimentstoachieveanefficientchitosanbaseddnavaccinedeliverysystem
AT florindohelenaf designofexperimentstoachieveanefficientchitosanbaseddnavaccinedeliverysystem
AT costadiana designofexperimentstoachieveanefficientchitosanbaseddnavaccinedeliverysystem
AT sousaangela designofexperimentstoachieveanefficientchitosanbaseddnavaccinedeliverysystem